SK Life Science, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2002-01-01
- Employees
- 101
- Market Cap
- -
An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2013-01-24
- Lead Sponsor
- SK Life Science, Inc.
- Target Recruit Count
- 47
- Registration Number
- NCT00210652
A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-04-25
- Last Posted Date
- 2012-08-02
- Lead Sponsor
- SK Life Science, Inc.
- Target Recruit Count
- 300
- Registration Number
- NCT00109083
© Copyright 2024. All Rights Reserved by MedPath